Aditxt (ADTX) Change in Receivables (2021 - 2026)
Aditxt (ADTX) recorded quarterly Change in Receivables of $11974.0 in Q1 2026, up 130.56% quarter-over-quarter from -$39182.0 in Q4 2025, and up 1009.19% on a YoY basis from $1079.5 in Q1 2025.
Aditxt (ADTX) Change in Receivables (2021 - 2026) Analysis & Trends
Aditxt's Change in Receivables history runs 6 years deep, the most recent figure standing at $11974.0 for Q1 2026.
- In Q1 2026, Change in Receivables rose 1009.19% year-over-year to $11974.0; the TTM figure through Mar 2026 stood at -$30144.0 (up 92.17% YoY), while the FY2025 annual figure was -$43435.0, up 88.1% from the prior year.
- Change in Receivables was $11974.0 for Q1 2026 at Aditxt, up from -$39182.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $208802.0 in Q4 2022 to a low of -$308272.0 in Q4 2024.
- Historically, Change in Receivables has averaged -$4580.6 across 5 years, with a median of -$1317.0 in 2025.
- The sharpest annual moves came in 2024 and 2026: Change in Receivables tumbled 775.77% in 2024, then surged 1009.19% in 2026.
- A 5-year view of Change in Receivables shows it stood at $208802.0 in 2022, then sank by 78.15% to $45618.0 in 2023, then tumbled by 775.77% to -$308272.0 in 2024, then jumped by 87.29% to -$39182.0 in 2025, then jumped by 130.56% to $11974.0 in 2026.
- The last three Change in Receivables figures came in at $11974.0 (Q1 2026), -$39182.0 (Q4 2025), and -$561.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 11,974.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,974.00 |
| Mar 31, 2026 | 11,974.00 |
| Dec 31, 2025 | -39,182.00 |
| Dec 31, 2025 | -39,182.00 |
| Sep 30, 2025 | -561.00 |
| Sep 30, 2025 | -561.00 |
| Jun 30, 2025 | -2,375.00 |
| Jun 30, 2025 | -2,375.00 |
| Mar 31, 2025 | -1,317.00 |
| Mar 31, 2025 | -1,317.00 |
| Dec 31, 2024 | -308,272.00 |
| Dec 31, 2024 | -308,272.00 |
| Sep 30, 2024 | -54,887.00 |
| Sep 30, 2024 | -54,887.00 |
| Jun 30, 2024 | -20,450.00 |
| Jun 30, 2024 | -20,450.00 |
| Mar 31, 2024 | 18,718.00 |
| Mar 31, 2024 | 18,718.00 |
| Dec 31, 2023 | 45,618.00 |
| Dec 31, 2023 | 45,618.00 |